1. Badorrek P, Dick M, Schauerte A, et al. A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis. Int J Clin Pharmacol Ther. 2009;47:71-77. PMID: 19203562
2. Benitez HH, Arvizu VM, Gutiérrez DJ, et al. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma]. Rev Alerg Mex. 2005;52:90-95. PMID: 16158782
3. Day JH, Briscoe MP, Rafeiro E, Hewlett D, Jr., Chapman D, Kramer B. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2004;25:59-68. PMID: 15055564
4. Day JH, Briscoe MP, Rafeiro E, et al. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit. Allergy Asthma Proc. 2005;26:275-282. PMID: 16270720
5. Dolovich J, Moote DW, Mazza JA, Clermont A, PetitClerc C, Danzig M. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis. Ann Allergy. 1994;73:235-239. PMID: 8092558
6. Kyrein HJ, Horak F, Nirnberger G, Rehn D. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber. Arzneimittelforschung. 1996;46:794-799. PMID: 9125281
7. Li L, Wang R, Cui L, Guan K. Efficacy of montelukast as prophylactic treatment for seasonal allergic rhinitis. Ear Nose Throat J. 2018;97:E12-e16. PMID: 30036440
8. Liu Y, Ye XJ, Zhao CL, Ji Q. [The effect of combined therapy on seasonal allergic rhinitis]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30:1049-1052. PMID: 29798036
9. Modgill V, Badyal DK, Verghese A. Efficacy and safety of montelukast add-on therapy in allergic rhinitis. Methods Find Exp Clin Pharmacol. 2010;32:669-674. PMID: 21225018
10. Ouyang Y, Fan E, Li Y, Zhang L. [Onset feature and efficacy of early interventional treatment of Artemisia pollinosis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;49:272-276. PMID: 24931013
11. Qu S, Li T, Chen Y, Lin Z, Ou Z. [The role of leukotriene D4 antagonist in allergic rhinitis with steroid resistance]. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2005;19:557-559. PMID: 16176012
12. Wang R, Zhang C. [Clinical evaluation of Montelukast plus Budesonide nasal spray and Desloratadine citrate disodium in treating moderate and severe persistent allergic rhinitis]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015;29:2041-2043. PMID: 27101674

1. Lotufo JP, Vieira SE, Ejzenberg BL, Okay Y. Montelukast versus beclometasone in children and adolescent allergic rhinitis treatment. Pediatria (sao paulo), 2002, 24(4‐Mar), 105‐111
https://www.cochranelibrary.com/central/doi/10.1002/central/CN-00477453/full
2. Di Lorenzo G, Pacor ML, Pellitteri Esposito M, Lo Bianco C, Corrocher R, et al. A double-blind, placebo-controlled comparison of treatments with fluticasone propionate, cetirizine and montelukast administered as monotherapy and as association, in patients with seasonal allergic rhinitis. Allergy, 2002, 57(s73), 46‐47
https://www.cochranelibrary.com/central/doi/10.1002/central/CN-00549174/full
3. Dempsey OJ, Wilson AM, Sims EJ, Lipworth BJ. A comparison of once daily topical budesonide (BUD) and oral montelukast (MON) in seasonal allergic rhinitis (SAR) and asthma. European respiratory society, 1999 | added to CENTRAL: 30 April 2004 | 2004 Issue 2
https://www.cochranelibrary.com/central/doi/10.1002/central/CN-00452521/full
4. Ciebiada M, Gorska‐Ciebiada M, Gorski P. Fexofenadine with either montelukast or a low-dose inhaled corticosteroid (fluticasone) in the treatment of patients with persistent allergic rhinitis and newly diagnosed asthma. Archives of medical science, 2009, 5(4), 564‐569
https://www.cochranelibrary.com/central/doi/10.1002/central/CN-00744010/full